Literature DB >> 26163194

Immunological features underlying viral hemorrhagic fevers.

Ilhem Messaoudi1, Christopher F Basler2.   

Abstract

Several enveloped RNA viruses of the arenavirus, bunyavirus, filovirus and flavivirus families are associated with a syndrome known as viral hemorrhagic fever (VHF). VHF is characterized by fever, vascular leakage, coagulation defects and multi organ system failure. VHF is currently viewed as a disease precipitated by viral suppression of innate immunity, which promotes systemic virus replication and excessive proinflammatory cytokine responses that trigger the manifestations of severe disease. However, the mechanisms by which immune dysregulation contributes to disease remain poorly understood. Infection of nonhuman primates closely recapitulates human VHF, notably Ebola and yellow fever, thereby providing excellent models to better define the immunological basis for this syndrome. Here we review the current state of our knowledge and suggest future directions that will better define the immunological mechanisms underlying VHF.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26163194      PMCID: PMC4593727          DOI: 10.1016/j.coi.2015.06.003

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  102 in total

1.  A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus.

Authors:  Amy L Hartman; Jonathan S Towner; Stuart T Nichol
Journal:  Virology       Date:  2004-10-25       Impact factor: 3.616

2.  Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever.

Authors:  Mike Bray; Thomas W Geisbert
Journal:  Int J Biochem Cell Biol       Date:  2005-03-07       Impact factor: 5.085

3.  The Pathology of the Liver in Yellow Fiver.

Authors:  O Klotz; T H Belt
Journal:  Am J Pathol       Date:  1930-11       Impact factor: 4.307

4.  Immunohistochemical examination of the role of Fas ligand and lymphocytes in the pathogenesis of human liver yellow fever.

Authors:  Juarez Antonio Simões Quaresma; Vera Lucia Reis Souza Barros; Elaine Raniero Fernandes; Carla Pagliari; Fernanda Guedes; Pedro Fernando da Costa Vasconcelos; Heitor Franco de Andrade Junior; Maria Irma Seixas Duarte
Journal:  Virus Res       Date:  2005-10-10       Impact factor: 3.303

Review 5.  Molecular mechanisms involved in the early steps of flavivirus cell entry.

Authors:  Bärbel Kaufmann; Michael G Rossmann
Journal:  Microbes Infect       Date:  2010-12-10       Impact factor: 2.700

6.  Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus) III. Clinical laboratory values.

Authors:  Elena Sbrana; Shu-Yuan Xiao; Vsevolod L Popov; Patrick C Newman; Robert B Tesh
Journal:  Am J Trop Med Hyg       Date:  2006-06       Impact factor: 2.345

7.  Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity.

Authors:  F J Neumann; I Ott; N Marx; T Luther; S Kenngott; M Gawaz; M Kotzsch; A Schömig
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-12       Impact factor: 8.311

8.  Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection.

Authors:  F Villinger; P E Rollin; S S Brar; N F Chikkala; J Winter; J B Sundstrom; S R Zaki; R Swanepoel; A A Ansari; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

9.  Structure of the Ebola VP35 interferon inhibitory domain.

Authors:  Daisy W Leung; Nathaniel D Ginder; D Bruce Fulton; Jay Nix; Christopher F Basler; Richard B Honzatko; Gaya K Amarasinghe
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-02       Impact factor: 11.205

10.  Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery.

Authors:  Tsung-Hsien Chang; Toru Kubota; Mayumi Matsuoka; Steven Jones; Steven B Bradfute; Mike Bray; Keiko Ozato
Journal:  PLoS Pathog       Date:  2009-06-26       Impact factor: 6.823

View more
  11 in total

1.  Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.

Authors:  Megan R Edwards; Gai Liu; Chad E Mire; Suhas Sureshchandra; Priya Luthra; Benjamin Yen; Reed S Shabman; Daisy W Leung; Ilhem Messaoudi; Thomas W Geisbert; Gaya K Amarasinghe; Christopher F Basler
Journal:  Cell Rep       Date:  2016-02-11       Impact factor: 9.423

Review 2.  Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.

Authors:  Qianya Wan; Dan Song; Huangcan Li; Ming-Liang He
Journal:  Signal Transduct Target Ther       Date:  2020-07-13

Review 3.  The Role of Exosomal VP40 in Ebola Virus Disease.

Authors:  Michelle L Pleet; Catherine DeMarino; Benjamin Lepene; M Javad Aman; Fatah Kashanchi
Journal:  DNA Cell Biol       Date:  2017-02-08       Impact factor: 3.311

4.  Retinoic Acid Inducible Gene I and Protein Kinase R, but Not Stress Granules, Mediate the Proinflammatory Response to Yellow Fever Virus.

Authors:  Guillaume Beauclair; Felix Streicher; Maxime Chazal; Daniela Bruni; Sarah Lesage; Ségolène Gracias; Salomé Bourgeau; Laura Sinigaglia; Takashi Fujita; Eliane F Meurs; Frédéric Tangy; Nolwenn Jouvenet
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

5.  Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction.

Authors:  Michelle L Pleet; Allison Mathiesen; Catherine DeMarino; Yao A Akpamagbo; Robert A Barclay; Angela Schwab; Sergey Iordanskiy; Gavin C Sampey; Benjamin Lepene; Sergei Nekhai; M J Aman; Fatah Kashanchi
Journal:  Front Microbiol       Date:  2016-11-07       Impact factor: 5.640

6.  Mechanisms of African swine fever virus pathogenesis and immune evasion inferred from gene expression changes in infected swine macrophages.

Authors:  James J Zhu; Palaniappan Ramanathan; Elizabeth A Bishop; Vivian O'Donnell; Douglas P Gladue; Manuel V Borca
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

Review 7.  Update in Viral Infections in the Intensive Care Unit.

Authors:  Paraskevi C Fragkou; Charalampos D Moschopoulos; Emmanouil Karofylakis; Theodoros Kelesidis; Sotirios Tsiodras
Journal:  Front Med (Lausanne)       Date:  2021-02-23

8.  T-Cells and Interferon Gamma Are Necessary for Survival Following Crimean-Congo Hemorrhagic Fever Virus Infection in Mice.

Authors:  David W Hawman; Kimberly Meade-White; Shanna Leventhal; Aaron Carmody; Elaine Haddock; Kim Hasenkrug; Heinz Feldmann
Journal:  Microorganisms       Date:  2021-01-29

9.  Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles.

Authors:  Michelle L Pleet; James Erickson; Catherine DeMarino; Robert A Barclay; Maria Cowen; Benjamin Lepene; Janie Liang; Jens H Kuhn; Laura Prugar; Spencer W Stonier; John M Dye; Weidong Zhou; Lance A Liotta; M Javad Aman; Fatah Kashanchi
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

10.  Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury.

Authors:  Adam L Bailey; Liang-I Kang; Luiz Gonzaga Francisco de Assis Barros D'Elia Zanella; Cássia G T Silveira; Yeh-Li Ho; Lander Foquet; Greg Bial; Broc T McCune; Amaro Nunes Duarte-Neto; Archana Thomas; Hans-Peter Raué; Kathleen Byrnes; Esper G Kallas; Mark K Slifka; Michael S Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-02       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.